MAD2L1
TRUNCATED 175 aa (canonical 205 aa) · UniProt Q13257 · CDLMPS
chr4:120065801:-:ATT:ENST00000296509.11
AI summary Truncation deletes a confidently-folded N-terminal helix docked against the HORMA fold core, though the core domain itself stays intact.
This truncation removes a 23-residue helix (canonical residues 13-35, pLDDT 0.965) that the structural model places in extensive, high-confidence contact with 35 residues spread across the rest of the canonical fold (mean PAE 1.38 Å) — a load-bearing element rather than a peripheral decoration. However, no real InterPro domain boundary falls in this stretch (HORMA domain and Mad2-like signature all begin at residue 8-15 and extend to ~197-205, so the core fold's catalytic/binding architecture is formally retained), and DeepLoc/SignalP/TargetP show no localization or targeting change.
MAD2L1's checkpoint function depends on a conformational switch (open/closed HORMA states) that mediates MAD1 and Cdc20 binding at kinetochores; losing a helix this tightly integrated with the fold's contact network plausibly perturbs that conformational machinery even though the primary HORMA/Mad2-like domain annotation nominally survives. The shared-region RMSD (2.79 Å) that might otherwise support a broader refold claim is not usable here since the isoform's own structural confidence (pTM 0.59, shared pLDDT 0.64) fails the reliability gate, so this reads as a discrete loss of a docked N-terminal helix rather than evidence of whole-core reorganization.
Detection of this alternative start is weak (1/6 cell lines, low initiation efficiency, no validated MS peptide) and disease/germline variant signals in the removed region show no real enrichment (all ClinVar hits benign/uncertain, gnomAD depletion ratio tolerant), so confidence rests mainly on the structural contact evidence, not on independent functional-importance corroboration.
Folding
Evidence — click any tile for the differential-region detail
LLM reasoning
How well is the isoform-unique region conserved at the amino-acid level across primates (mean percent identity)? High AA identity in close relatives argues the alternative protein is real and translated, not a sequencing or annotation artifact. (Reading-frame intactness is shown as context.)
Comparison
Sequence conservation · primate
mean AA identity over the differential ORF is the score basis; frame intactness across the clade is context
| Conservation metric | Canonical ORF | Differential ORF |
|---|---|---|
| Mean AA identity | 100% | 99% |
| Frame intact (fraction of species) | 96% | 100% |
| Species aligned | 25 | 25 |
| Species frame-intact | 24 | 25 |
| Start codon conserved | 100% | 100% |
| Deepest intact species | Microcebus_murinus | Microcebus_murinus |
| Phylo depth (MRCA) | 7 | 7 |
The same amino-acid identity test across mammals. Conservation over deeper evolutionary distance is stronger evidence the ORF is under selection to be translated. (Reading-frame intactness is shown as context.)
Comparison
Sequence conservation · mammalian
mean AA identity over the differential ORF is the score basis; frame intactness across the clade is context
| Conservation metric | Canonical ORF | Differential ORF |
|---|---|---|
| Mean AA identity | 95% | 93% |
| Frame intact (fraction of species) | 35% | 80% |
| Species aligned | 20 | 20 |
| Species frame-intact | 7 | 16 |
| Start codon conserved | 95% | 95% |
| Deepest intact species | Loxodonta_africana | Loxodonta_africana |
| Phylo depth (MRCA) | 12 | 12 |
phyloP / phastCons measure per-base evolutionary constraint. A high absolute phyloP over the differential region means the sequence itself is under strong purifying selection — evidence it is coding and does something. (Enrichment over the shared core is shown as context only.)
Comparison
Per-base conservation · differential region
absolute mean phyloP over the differential region is the score basis (high = strong purifying selection); the shared column and enrichment are context, not the claim
| Track | Differential | Shared | vs shared |
|---|---|---|---|
| phyloP mean | 4.08 | 4.3 | 0.95 |
| phastCons mean | 0.819 | 0.908 | — |
Start site · canonical vs isoform
initiation context + per-base conservation at each start codon
| Property | Canonical | Isoform |
|---|---|---|
| Start codon | ATG | ATT |
| Kozak context (−9..+4) | TCCCTGGCCATGG | ATCAACAGCATTT |
| phyloP at start codon | 6.88 | 4.32 |
| phastCons at start codon | 1 | 1 |
| phyloP over Kozak window | 2.69 | 4.93 |
| phastCons over Kozak window | 0.479 | 1 |
| Kozak mismatch — full consensus | 4 | 7 |
| Kozak window GC content | 0.692 | 0.308 |
LLM reasoning
Is the alternative start used in more than one cell line? Reproducible initiation across independent samples argues against a one-off ribosome artifact.
Comparison
Per-cell-line usage · canonical vs isoform
Fisher q = 0.0263
| Cell line | Canonical | Isoform | p-value |
|---|---|---|---|
| HeLa | 62.7 | 1.82 | 0.0263 |
| K562 | 20.5 | — | — |
| U2OS | 11 | — | — |
How efficiently ribosomes initiate at this start (TIS) relative to background, per cell line. Strong, reproducible initiation supports a genuine translation event.
Comparison
Start-Site Usage · canonical vs isoform
ribosome initiation efficiency at the canonical start vs this alternative start, per cell line
| Cell line | Canonical | Isoform |
|---|---|---|
| HeLa | 1.5 | 0.0435 |
| K562 | 0.545 | — |
| U2OS | 0.174 | — |
Were tryptic peptides unique to the differential region detected by mass spec? Direct peptide evidence is the strongest proof the isoform protein exists.
Comparison
Peptide Evidence (canonical vs isoform)
isoform-unique peptides are direct evidence the alternative protein exists
| Feature | Canonical | Isoform |
|---|---|---|
| Tryptic peptides (in-silico) | 34 | 1 |
| Validated by mass-spec | 0 | 0 |
| Isoform-unique peptides | — | 1 |
Details
Peptide Evidence (canonical vs isoform)
- peptide MLYQRGIYPSETFTR 0–15
LLM reasoning
Do the predicted localization features (DeepLoc prediction, sorting signals, or membrane association) differ between the canonical and the isoform? A protein with changed localization features acts in a different cellular context.
Comparison
Subcellular localization (DeepLoc)
no localization-feature change
| Property | Canonical | Isoform |
|---|---|---|
| Predicted location | Cytoplasm | Cytoplasm |
| Sorting signals | Nuclear export signal | Nuclear export signal |
| Membrane | Soluble | Soluble |
Do N-terminal targeting signals (SignalP secretion, TargetP mitochondrial/chloroplast) differ between canonical and isoform? N-terminal changes most directly add or remove targeting peptides.
LLM reasoning
Does healthy human germline variation (gnomAD) avoid this region (depletion ratio < 1×), and is it intrinsically constrained (ESM-C constraint delta > 0)? Depletion of population variation plus high sequence constraint mean the region resists change — it is functionally important. Scored only where the unique region is canonical coding sequence, i.e. on truncations. gnomAD is a tolerance catalogue, not a disease one; disease/cancer variants (ClinVar / COSMIC) live in M2.
Comparison
Germline Variants · differential vs shared region
gnomAD (population) variant density per nucleotide — depletion ratio < 1× means healthy human variation avoids the region (constrained), the M1 basis alongside ESM-C constraint
| Variant set | Differential | Shared | Depletion ratio |
|---|---|---|---|
| gnomAD variants | 64 | 219 | 1.7× |
Sequence constraint (ESM-C) · differential vs shared region
lower LLR = more constrained; enrichment = differential / conserved
| Property | Differential | Shared | Enrichment |
|---|---|---|---|
| ESM-C mean LLR | -0.0193 | -0.0567 | — |
| Constrained positions | 0 | 1 | — |
Predicted-damaging variants · germline (gnomAD)
AlphaMissense / ESM-C / LoF calls per region (length-normalized)
| Variant set | Differential | Shared | Enrichment |
|---|---|---|---|
| Scorable variants | 64 | 219 | 1.6× |
| Damaging variants | 32 | 112 | 1.6× |
| — of which loss-of-function | 3 | 11 | 1.5× |
| AlphaMissense-pathogenic | 19 | 64 | 1.7× |
Predictor scores · germline (gnomAD)
scored: 360 ESM-C · 254 AlphaMissense
| Property | Differential | Shared |
|---|---|---|
| Mean ΔLLR (ESM-C) | -5.67 | -5.81 |
| Min ΔLLR (ESM-C) | -14.1 | -13.7 |
| Mean AlphaMissense | 0.572 | 0.495 |
Are disease (ClinVar / COSMIC) variants enriched per nucleotide in the differential region versus the shared core (disease enrichment ratio ≥ 1×)? Disease variants concentrating in the unique region tie it to phenotype.
Comparison
Clinical-variant burden · differential vs shared region
counts per region; ratio is density-normalized (variants per nucleotide, differential ÷ shared — ≥1× = disease variants concentrate in the differential region, the M2 basis)
| Variant set | Differential | Shared | Enrichment |
|---|---|---|---|
| Disease variants | 21 | 86 | 1.4× |
| Pathogenic | 0 | 0 | — |
Predicted-damaging variants · disease (ClinVar/COSMIC)
AlphaMissense / ESM-C / LoF calls per region (length-normalized)
| Variant set | Differential | Shared | Enrichment |
|---|---|---|---|
| Scorable variants | 21 | 86 | 1.4× |
| Damaging variants | 9 | 59 | 0.86× |
| — of which loss-of-function | 2 | 14 | 0.81× |
| AlphaMissense-pathogenic | 6 | 31 | 1.1× |
Predictor scores · disease (ClinVar/COSMIC)
scored: 360 ESM-C · 254 AlphaMissense
| Property | Differential | Shared |
|---|---|---|
| Mean ΔLLR (ESM-C) | -5.23 | -7.53 |
| Min ΔLLR (ESM-C) | -12.9 | -13.4 |
| Mean AlphaMissense | 0.62 | 0.54 |
LLM reasoning
Does the gained/lost region fold into ordered structure (pLDDT) and shift the protein's biophysical character (charge, hydropathy, disorder)? Structured, biophysically distinct regions are more likely to be functional.
Comparison
Structure (ESMFold2) · canonical vs isoform
TM-score 0.822 · RMSD 2.4 Å
| Metric | Canonical | Isoform |
|---|---|---|
| pLDDT (whole protein) | 0.938 | 0.637 |
Fold confidence · differential vs shared region
mean ESMFold2 pLDDT in each region
| Metric | Differential | Shared | Enrichment |
|---|---|---|---|
| pLDDT | 0.896 | 1.2 | 0.74 |
The shared region is the stretch of protein identical in both the isoform and the canonical (the canonical body for an extension; the post-truncation body for a truncation). Folded in both contexts it normally comes out nearly identical, so its Cα backbone RMSD ≈ 0. A high shared-region RMSD (superposed on the shared residues only, from the ESMFold2 structures) means the extension or truncation reorganizes how the retained region folds — a rare, high-interest functional signal. TM-score is a length-normalized companion; the check only fires when both structures are confidently folded, and uORF/altORF isoforms (no shared region) are not evaluable.
Comparison
Shared-region structural change
Cα RMSD superposed on the shared residues only; TM-score is length-normalized · shared-region Cα RMSD 2.79 Å · shared TM-score 0.885 · shared region 174 aa · min shared pLDDT 0.637 · global TM-score 0.822 · global RMSD 2.4 Å
| Property | Canonical | Isoform |
|---|---|---|
| Shared-region pLDDT | 0.946 | 0.637 |
Does the differential region contain actual secondary structure — a helix or strand — rather than coil? ESMFold2 predicts coordinates but no secondary structure, so elements are assigned from those coordinates (P-SEA, Cα geometry). Because they are derived from a prediction, each element carries its own mean pLDDT: a geometrically clean helix running through a disordered stretch is geometry fitted to a guess, so BOTH length and confidence are required to score. The direction differs by ORF type — an extension GAINS the element (a candidate functional addition), a truncation LOSES one, and there the element is read off the canonical structure because the removed segment exists only in it. This says nothing about whether the element is integrated with the rest of the fold; the contact and PAE evidence in this same category answers that.
Comparison
Secondary structure · differential vs shared region
helices and strands assigned from the predicted coordinates (P-SEA)
| Metric | Differential | Shared |
|---|---|---|
| Alpha helices | 1 | 2 |
| Beta strands | 0 | 5 |
| Longest element (aa) | 23 | 21 |
| Mean pLDDT | 0.96 | 0.96 |
Elements and coordinates
1 in the differential region, 7 in the shared core — residue numbering is 1-based on the protein holding the region
| Removed (canonical) | Shared core |
|---|---|
| alpha helix 13–35 23 aa · pLDDT 0.96 | alpha helix 59–78 20 aa · pLDDT 0.96 |
| — | beta strand 83–89 7 aa · pLDDT 0.96 |
| — | beta strand 100–106 7 aa · pLDDT 0.97 |
| — | alpha helix 121–141 21 aa · pLDDT 0.94 |
| — | beta strand 148–156 9 aa · pLDDT 0.97 |
| — | beta strand 177–187 11 aa · pLDDT 0.95 |
| — | beta strand 191–200 10 aa · pLDDT 0.97 |
Below threshold
0 in the differential region, 3 in the shared core — shorter than 6 aa or below pLDDT 0.70, so not counted above
| Removed (canonical) | Shared core |
|---|---|
| — | beta strand 43–47 5 aa · pLDDT 0.96 |
| — | beta strand 52–56 5 aa · pLDDT 0.97 |
| — | beta strand 167–170 4 aa · pLDDT 0.87 |
LLM reasoning
Does the isoform gain or lose a real InterPro functional domain in the differential region (disorder/structural-only signatures excluded)? Gaining or losing a domain changes function directly.
Comparison
Domains & motifs (canonical vs isoform)
gained = only in the isoform; lost = only in the canonical
| Feature | Canonical | Isoform |
|---|---|---|
| InterPro domains | 6 | 6 |
| Short linear motifs | 2 | 2 |
Biophysical character of the isoform-differential region versus the shared canonical core — pI, hydropathy, charge, disorder and related properties. Descriptive; the folding (P1) score keys off the GRAVY / charge / disorder deltas.
Comparison
Biophysics · differential vs shared region
highlighted rows are enriched in the differential region
| Property | Differential | Shared | Enrichment |
|---|---|---|---|
| Isoelectric point (pI) | 4.38 | 4.74 | 0.924 |
| Hydropathy (GRAVY) | 0.458 | -0.211 | -2.17 |
| Fraction charged | 0.161 | 0.274 | 0.588 |
| Disorder fraction | -0.0071 | 0.0682 | -0.104 |
| Disorder-promoting | 0.548 | 0.48 | 1.14 |
| Low-complexity fraction | 0 | 0 | — |
| Prion-like fraction | 0.323 | 0.223 | 1.45 |
| LLPS score | 0.227 | 0.127 | 1.79 |
| π–π propensity | 0.258 | 0.229 | 1.13 |
| Aromaticity | 0.0968 | 0.0914 | 1.06 |
| Instability index | 38.1 | 51.9 | 0.733 |
| Shannon entropy | 3.54 | 4.06 | 0.873 |
| Normalized complexity | 0.82 | 0.938 | 0.873 |
Sparse-autoencoder (SAE) interpretability features on the ESM-C residual stream, comparing the isoform against the canonical protein. This is the S3 criterion — a presence check that fires when any interpretable feature is gained or lost. Only the top 30 features per category (ranked by activation, prevalence ≥ 2) are saved; each table shows the top 10 interpretable features, and generic / "unknown" features are hidden unless you expand it. What are SAE features? →
Part 1 · Global feature comparison
Which SAE features fire in the isoform vs the canonical protein, across the whole sequence.
Isoform-only features — 12 total (prevalence ≥ 2)
| Feature | Label | Description | Activation | Prevalence |
|---|---|---|---|---|
| #512 | Short functional domain segments | Short sequence segments distributed across diverse proteins, with peaks that often fall within structured catalytic, transporter, or fold-defining domains as well as occasional acidic/charged stretches and flexible linkers. | 4.80 | 6 |
| #14169 | Pocket-flanking loop residues | Residue-level signal for pocket-adjacent positions within structured domains: short loop/turn or strand-edge residues (often acidic or small/flexible) that border catalytic, metal/cofactor, or ligand-binding sites and channels, typically in the mature/catalytic domain rather than signal peptides or low-complexity regions | 2.16 | 2 |
| #13982 | Bromodomain and HTH core signature | A eukaryotic nuclear recognition-module signature that targets compact all-alpha binding cores—most strongly bromodomains (acetyl-lysine reader pocket and adjoining helices) but also helix-turn-helix/winged-helix nucleic-acid-binding cores (e.g., La/ARID/ETS/IRF/HSF). The shared signal is a conserved hydrophobic/basic recognition element within these reader cores. | 2.14 | 2 |
| #1390 | Exposed beta strand interfaces | Solvent-exposed edge beta-strands and adjacent loop segments that serve as assembly or binding interfaces—most prominently in extracellular/virion structural systems (phage tails and type VI secretion), but also in analogous edge strands of diverse beta-sheet proteins. | 2.10 | 4 |
| #11302 | Low-complexity IDRs and propeptides | Low-complexity, compositionally biased segments (intrinsically disordered or simple-architecture helices), including propeptides and flexible loops, enriched in small/polar/charged residues and sometimes alanine-rich; commonly found at N-termini of secreted/viral proteins and often overlapping N-linked glycosylation sequons in flexible regions. | 2.07 | 2 |
| #3443 | Noncatalytic nuclease helix-coil regions | Regions within type II restriction endonucleases and related nucleases, frequently overlapping structured helical elements and adjacent coil segments, but generally avoiding the catalytic core residues themselves. | 2.05 | 2 |
| #707 | C-terminal helix-capping patches | Short C-terminal segments at the end of the last α-helix and into the terminal coil — 10-30 aa windows that frequently coincide with helix-capping regions of complex subunits and membrane-associated proteins, often serving as interaction-prone termini | 2.03 | 3 |
| #10439 | Ubiquitous structural anchor signal | Ubiquitous "structural anchor" signal: short, ordered residues at secondary-structure elements and their junctions—helix/strand cores or caps and loop→secondary-structure transitions—often adjacent to functional motifs; in membrane proteins this frequently maps at the edges of transmembrane helices (juxtamembrane cytoplasmic/extracellular residues) with secondary peaks within the TM, and it avoids disordered/hydrophobic signal peptides. | 2.03 | 2 |
| #3642 | Gly/Ala/Pro-rich disordered segments | Glycine/alanine/proline-rich low-complexity stretches, frequently within annotated disordered regions, that share a recurring small-residue context (Gly-Val/Ala-Xaa-Ala/Pro patterns). | 2.01 | 2 |
| #16277 | GG/GxG nucleic-acid-binding beta-strand | A short beta-strand motif that forms part of the nucleic acid–binding face of small beta-barrel RNA-binding folds (Sm/LSm and S1/OB), characterized by GG/GxG micro-motifs and neighboring charged residues; the same glycine/charge-rich beta-strand pattern recurs in diverse proteins and can trigger broader, weaker activation. | 1.95 | 2 |
| #2441 | Basic helical phosphate-binding motifs | Short conserved motifs found in nucleotide/nucleic-acid-handling enzymes and DNA-binding regulators, with additional hits in membrane transporters of metal/siderophore systems; peaks frequently fall on Lys/Arg-containing helical segments but also on adjacent polar residues | 1.92 | 2 |
| #6591 | Secondary-structure capping linkers | Short linear capping/connector segments at secondary-structure termini (helix- or beta-edge to coil transitions), enriched in helix‑breaking Pro/Gly and acidic residues and often containing an NFP(E/D/T)L‑like pattern; typically positioned at domain boundaries or inter‑helical/linker loops across diverse proteins. | 1.90 | 2 |
Canonical-only features — 68 total (prevalence ≥ 2)
| Feature | Label | Description | Activation | Prevalence |
|---|---|---|---|---|
| #11911 | Short Lys/Arg-rich patches | Short sequence patches—often Lys/Arg-enriched and sometimes mixed with acidic residues—typically 8–25 residues long, frequently occurring in disordered N-terminal segments but also within ordered regions of diverse proteins, often associated with RNA/ribosome-contact surfaces or assembly interfaces. | 7.81 | 15 |
| #15815 | Basic N-terminal targeting patch | Short, basic/polar N‑terminal leader/transit segment immediately after the initiator methionine (positions ~3–6) — i.e., the positively charged/polar start of signal peptides and organelle transit peptides, and more generally low‑acidic, disordered N‑terminal patches (including occasional cysteine‑rich starts) used for targeting, export, rRNA binding, or membrane topology cues | 7.67 | 4 |
| #16088 | Disordered mixed-charge linker patches | Short, mixed-charge, low-aromatic patches (rich in G/P/S/T/K/R/E/D) within intrinsically disordered regions, often at domain-flanking linkers of AAA+/P-loop ATPases and nucleic-acid–associated proteins. Marks generic polar/charged interaction or flexibility motifs rather than catalytic sites. | 6.52 | 10 |
| #5114 | Short N-terminal targeting arm | N-terminal segments (typically the first ~10 residues) across a wide range of bacterial, viral, and eukaryotic proteins. These are often signal/targeting/assembly arms, including RNA/DNA-binding tails, secretion/chaperone-binding regions, and assembly linkers. | 5.43 | 14 |
| #10704 | N-terminal PEST-like IDRs | Low-complexity, often acidic/proline-rich intrinsically disordered N-terminal tails of intracellular eukaryotic proteins, frequently overlapping annotated PEST-like segments. | 5.10 | 9 |
| #8974 | Short hydrophobic beta-strand edges | Generic detection of short hydrophobic β-strand segments and adjacent strand–loop junctions (often edge strands), frequently appearing at N-termini or disorder-to-order/domain boundaries, independent of protein function. | 5.05 | 3 |
| #13226 | N-terminal basic amphipathic helix | N-terminal amphipathic/basic helix or basic patch: a short, positively biased, polar/small–rich segment that forms the first α-helix (or a helical/disordered-to-helix patch) at the protein N-terminus, or within/just after long organelle transit peptides, used for targeting and macromolecular docking | 4.82 | 7 |
| #8538 | Sigma-70 region-2 helical scaffold | Amphipathic alpha-helical segments in well-ordered regions, with a strong specialization for the conserved helical core of sigma-70 region 2 in bacterial/organellar sigma factors; more generally, the feature marks long helices that serve as structural/interaction scaffolds across diverse proteins (regulatory, nucleic-acid–associated, proteostasis/translocation motors, and large modular biosynthetic enzymes). | 4.51 | 2 |
| #13964 | Short amphipathic alpha-helices | Short amphipathic alpha-helical segments enriched in leucine (and other hydrophobes) with interspersed basic residues, most prominently the helices that compose HEAT/ARM-like alpha-solenoid repeats but also analogous isolated N-terminal helices in diverse proteins | 4.31 | 2 |
| #12799 | N-terminal leaders and arms | N-terminal segments of mature proteins — including signal/transit peptide leaders, the early residues immediately following signal cleavage, and N-terminal structural "arm" regions that serve assembly, targeting, or oligomerization roles in a wide variety of proteins (viral capsids/tails/portals/baseplates, encapsulins, secreted/lipoproteins, pore-formers, CRISPR/Cas components, and nuclear/ribosome biogenesis factors). | 4.27 | 24 |
| #16098 | Disordered charged regulatory tails | Charged or low-complexity regulatory segments and selected conserved motifs in eukaryotic signaling and ubiquitin/ubiquitin-like pathway proteins. The feature most often fires on long disordered N-/C-terminal tails or interdomain linkers enriched in Ser/Thr/Pro and acidic residues or in Lys/Arg-rich patches, and also on a conserved Trp-Ser-containing motif positioned near the PI3K Ras-binding domain in class II PI3Ks. | 3.95 | 26 |
| #7151 | N-terminal amphipathic helix start | N-terminal amphipathic alpha-helix initiation (the first helix and its N-cap/helix-start segment), marking the transition from a flexible N-terminus into the first stable helical element; a generic structural motif seen across diverse proteins and taxa, occasionally recurring at the starts of internal helices. | 3.82 | 4 |
| #13075 | N-terminal beta1 anchoring strand | Short, extreme N-terminal segment that most often corresponds to the first beta-strand (beta1) of the domain and its immediate flanks, capturing an amphipathic, beta-strand-like sequence pattern used to anchor the fold, contribute to active/ligand sites, or provide an interface for assembly in multi-protein complexes; compositionally enriched for alternating hydrophobic residues (L/I/V/F/Y) with Ser/Thr and charged residues (Lys/Glu/Asp), with Tyr frequently early. | 3.69 | 16 |
| #3026 | Short amphipathic contact helix | Short amphipathic alpha-helical segments (often in the first structured domain), characterized by alternating charged/polar and small hydrophobic residues, serving as generic interface/ligand-contact helices across diverse folds (DNA-binding, protein–protein, and cofactor/substrate-adjacent helices). | 3.46 | 3 |
| #13225 | Membrane hydrophobic helix signature | Hydrophobic alpha-helical membrane-association signature: the feature fires on short clusters of hydrophobic residues that form signal peptides and transmembrane helices (including amphipathic membrane-anchoring helices); in soluble NTPases it often also aligns with a conserved hydrophobic helix in the ATPase core. | 3.19 | 2 |
| #10995 | β-strand–rich extracellular interfaces | β-strand–rich interaction surfaces with strong enrichment in secreted/lumenal protein regions, but not exclusive to them; the feature targets β-strands and adjacent loops that are often post-translationally stabilized (N-glycans) in extracellular proteins, and analogous β-elements in certain intracellular trafficking and phosphoinositide-processing proteins. | 3.14 | 2 |
| #963 | N-terminal hydrophobic/aromatic module | Long, hydrophobic/aromatic N‑terminal blocks—most commonly the first membrane transmembrane helix together with the short periplasmic/lumenal loop and the start of the next helix (a helix–loop–helix insertion module); in non‑membrane cases, an analogous contiguous N‑terminal hydrophobic/aromatic patch within the core fold | 3.03 | 26 |
| #1160 | Low-complexity IDR boundary linkers | Long, low-complexity intrinsically disordered tails and linkers at domain boundaries (disorder-to-order junctions), enriched in polar, acidic/basic, and proline residues, found across eukaryotic regulatory proteins and retroviral/retrotransposon Gag polyproteins. | 2.98 | 17 |
| #7858 | Viral structural polyprotein detector | Detector of viral structural modules—especially capsid/coat proteins and plant-virus movement proteins—most prominently when they occur as segments of polyprotein precursors; it highlights long stretches within these regions, favoring intrinsically disordered/basic tails and the vicinity of proteolytic processing sites, and can extend into the capsid core. | 2.97 | 21 |
| #5335 | SEA domain autoproteolysis serine | Serine-centered feature that detects a conserved isolated serine within SEA (sea urchin sperm protein/enterokinase/agrin) domains of extracellular/membrane-anchored proteins, typically in the context S-S-x-Y-Q-E or similar around the SEA autoproteolysis loop; also fires on isolated solvent-exposed serines in short loops of other secreted/GPI-anchored proteins | 2.94 | 2 |
| #4652 | Disordered N-terminal flanks | Mixed-charge, polar/low-complexity N‑terminal (and other pre‑domain) flanking segments that lie immediately upstream of the first structured/catalytic module or processed peptide; typically intrinsically disordered or short amphipathic “helix-cap” elements, enriched in D/E/K/R/S/T/G/P (often Y), and generally avoiding conserved domain cores | 2.90 | 4 |
| #15329 | Terminal intrinsically disordered regions | Intrinsic structural disorder: long, unannotated terminal extensions and other extended segments outside annotated catalytic/structured domains (typically coil, low pLDDT), with low activation in well-folded domain cores | 2.78 | 2 |
| #4930 | Disordered coil-to-helix DNA contacts | Intrinsically disordered, low‑complexity regulatory segments of eukaryotic and viral DNA/chromatin‑associated proteins, with strongest signal at short coil‑to‑helix initiation sites that flank or begin DNA‑binding modules (e.g., the start of helix 1 in HMG‑box or homeodomain) and on analogous Lys/Arg‑rich tracts that contact or package DNA. | 2.77 | 16 |
| #10977 | Early N-terminal disordered patch | Short N-terminal patch at the extreme N-terminus (around residues 5–10), capturing the first distinctive segment of preproteins/precursors and N-terminal disordered tails; residue composition is heterogeneous but frequently polar (Ser/Thr) and/or charged. | 2.72 | 2 |
| #293 | Low-complexity FG-rich IDRs | Intrinsically disordered, low‑complexity segments used for protein–protein interactions, with a strong compositional bias (polar/charged, Pro/Gly) and particular sensitivity to phenylalanine‑containing short repeats (e.g., FG/FSFG) in large eukaryotic regulatory/scaffold proteins; avoids structured catalytic or coiled‑coil cores. | 2.68 | 6 |
| #14990 | Ordered noncatalytic alpha helices | Short runs of residues within well-ordered alpha helices that form helix-helix packing cores or protein-interaction helices in globular domains; the signal consistently avoids catalytic/metal-binding motifs and intrinsically disordered/low-complexity regions. | 2.67 | 3 |
| #15125 | N-proximal primase substrate-binding module | A specific N-proximal structured subregion within primase/polymerase catalytic domains, typically a short β-strand/helix element overlapping a substrate-binding residue and located upstream of the central catalytic motifs and C-terminal accessory modules. | 2.66 | 12 |
| #523 | N-terminal and juxtamembrane stalks | Long N-terminal and membrane-proximal segments — including polar/Ser/Thr-enriched low-complexity stretches that form simple helices or flexible linkers — at protein ends or near transmembrane junctions, i.e., membrane-proximal "stalks" and juxtamembrane/tail regions, as well as N-terminal targeting/regulatory helices. | 2.65 | 18 |
| #572 | Active-site flanking helices | Feature highlights helical segments within the catalytic core of small-molecule kinases and nucleotide-metabolism / nucleic-acid-acting enzymes, particularly helices flanking substrate-binding and active-site residues. | 2.58 | 6 |
| #151 | Terminal motifs and catalytic loops | Short linear recognition/processing motifs and adjacent strand/loop elements at protein termini and domain edges, and pinpoint residues in catalytic-loop neighborhoods of nucleotide/metal‑binding enzymes; in secreted/periplasmic proteins this includes signal-peptide/GPI/glycosylation–proximal stretches and N‑terminal periplasmic signaling segments, while in large cytosolic enzymes it spikes at hallmark motifs (P‑loop–adjacent, HRD catalytic loop, TOPRIM/Mg‑binding vicinity). | 2.57 | 7 |
Shared features by |Δ| activation — 830 total (prevalence ≥ 2)
| Feature | Label | Description | Δ activation | Iso act. | Canon act. | Iso prev. | Canon prev. |
|---|---|---|---|---|---|---|---|
| #5707 | INRE-like short charged blocks | Short internal sequence blocks with a recurring (I/L)-N-R-E-(P/I)-F–like motif and surrounding charged residues, found in cobalamin-dependent isomerases and in other diverse bacterial/archaeal proteins | -6.87 | 2.08 | 8.95 | 4 | 19 |
| #11660 | Short hydrophobic helical patches | Short, Φ-rich (hydrophobic/aromatic) sequence segments, typically helix-like patches. Most often these correspond to the h-region of signal peptides or single-pass membrane anchors in secreted/periplasmic proteins, but the feature also fires on short internal helices or aromatic hydrophobic binding patches within soluble enzymes and structural proteins. | -4.67 | 3.95 | 8.62 | 5 | 16 |
| #13334 | N-terminal IDR boundary | Recognition of short, low-complexity, intrinsically disordered N-terminal tails immediately upstream of the first folded domain; these segments are often Ser/Thr/Pro/Gly/Ala-biased and sometimes extend a few residues into the initial helix or the very beginning of the first domain (domain boundary/disorder-to-order transition), especially in transcription regulators and co-regulators. | -4.57 | 2.07 | 6.64 | 5 | 31 |
| #14027 | Arg-rich linker and Walker A | Disordered linker segments of AAA+ initiator/replication proteins, with strong activation on a conserved Arg-rich motif in the unstructured region preceding the AAA+ ATPase domain, and weaker secondary activation on the Walker A/P-loop and nearby ATP-binding residues | -3.48 | 4.96 | 8.45 | 3 | 13 |
| #4485 | Hydrophobic alpha-helical segments | Hydrophobic alpha-helical segments in soluble globular proteins, prominently a conserved helix near the active site of glycoside hydrolase family 27 alpha-galactosidases. | -3.02 | 14.45 | 17.47 | 63 | 90 |
| #7572 | Conserved catalytic helix motif | A conserved internal sequence/structural motif within enzyme catalytic domains, prominently exemplified by the "DRL(V/I)G(x)YEE" segment of the glutamate mutase epsilon subunit, where activation peaks on a short hydrophobic-aromatic stretch embedded in an α-helix close to cofactor/substrate binding residues. | -2.29 | 3.27 | 5.55 | 5 | 14 |
| #12109 | Proline-rich low-complexity IDRs | Eukaryotic intrinsically disordered, low‑complexity linkers and tails enriched in Pro/Ser/Thr/Gln/Gly—often containing proline‑rich motifs and S/T‑P dipeptides—that act as multivalent, PTM‑dense interaction platforms in large scaffold and regulatory proteins. | -2.24 | 2.29 | 4.53 | 5 | 27 |
| #15283 | Short α-helical interface motifs | Short α-helical segments, often embedded in or adjacent to low-complexity regions. These helices frequently serve as oligomerization interfaces or membrane/scaffold docking elements in large assemblies and can also occur as generic interface/capping helices within soluble enzyme complexes. Peak residues commonly include hydrophobic and aromatic positions (F/M/L/W) alongside polar A/G/P/S/T/V and charged E/D/K/Q/R. | -1.95 | 3.70 | 5.64 | 5 | 30 |
| #14446 | Domain start interaction hotspots | Segments at domain starts and junctions (often but not exclusively at the protein N-terminus or just after signal peptide cleavage) that nucleate assembly or transient partner binding; these include β–loop regions, helix caps/coiled-coil tips, short low-complexity acidic/lysine-rich tracts, and early helical segments adjacent to catalytic domains. | -1.93 | 2.74 | 4.67 | 16 | 35 |
| #15471 | Internal domain motif hotspots | Short internal sequence motifs within large catalytic or structural protein domains, with peaks typically falling on a single dominant residue flanked by a mix of small (Gly/Ala/Pro), aromatic (Tyr/Phe), and polar residues; activation is sparse across each protein and concentrated at a narrow internal hotspot. | -1.57 | 2.98 | 4.55 | 2 | 2 |
| #2073 | Hydrophobic C-terminal helical cores | Hydrophobic, conserved cores of late-appearing folded domains—predominantly all‑alpha helical bundle/scaffold regions—in large eukaryotic regulators, often lying at or just upstream of a C‑terminal catalytic/effector domain (e.g., HECT region, TBC/RasGAP cores, PDE catalytic core, pre‑PCI helices), with occasional recognition of analogous β‑rich domain cores in secreted oxidoreductases. | -1.52 | 2.11 | 3.63 | 3 | 25 |
| #786 | Compact helical/loop activation blocks | Regional activation in short blocks within bacterial and archaeal proteins, often in early helical or loop segments roughly within the first ~70 residues, but also occurring at internal structured elements (e.g., beta-strand/turn regions and substrate-binding helices) of various enzymes. | -1.30 | 2.54 | 3.85 | 3 | 20 |
| #2257 | Eukaryotic low-complexity IDRs | Intrinsic disorder/low-complexity signal: the feature marks long, compositionally biased IDRs in eukaryotic proteins—especially Lys/Arg-rich basic patches, Glu/Asp-rich acidic tracts, and Q/N/S/T-rich stretches—found in N-/C-terminal tails and inter-domain linkers, while avoiding well-folded domains and transmembrane helices; commonly seen in translation/RNA biogenesis factors and secretory/quality-control proteins. | -1.20 | 2.27 | 3.47 | 3 | 12 |
| #14081 | Disordered PPI motif regions | Intrinsically disordered, low‑complexity regions (IDRs) enriched in small/polar and acidic residues with frequent proline (including proline‑rich segments), marking protein–protein interaction modules that contain short linear motifs and transient alpha‑helical MoRFs, typically found in large scaffolds and regulatory tails across diverse taxa | -1.14 | 3.24 | 4.38 | 18 | 25 |
| #6544 | TESPA1/ITPRID cassette hotspot | Mammal-specific, family-restricted short internal segment around residues 200–250 shared by TESPA1 and ITPRID proteins; the model selects a single residue-level hotspot within this segment independent of residue identity. | +1.07 | 8.19 | 7.12 | 12 | 16 |
| #9237 | Glycine detector in disordered regions | Residue-identity detector for glycine (G), with a mild bias toward intrinsically disordered/low-complexity segments (often including very N-terminal residues); pan-taxonomic and function-agnostic, but activation is sparse and frequently absent, becoming detectable mainly in glycine-rich low-complexity contexts; occasional weak responses to other small/polar residues. | -1.02 | 4.41 | 5.43 | 4 | 7 |
| #4054 | Extreme N-terminal activation elements | Eukaryotic proteins’ extreme N‑terminal regulatory segments—either short disordered tails or the N‑terminal portion of the first folded domain (e.g., initial helix/strand)—serve as generic interaction/activation elements across nuclear and cytosolic regulators (transcription/RNA/RNP processing, genome maintenance, proteostasis/co‑chaperone systems). | -0.92 | 3.34 | 4.27 | 12 | 41 |
| #10474 | Fungal N-terminal regulatory tails | Extreme N-terminal segments of fungal proteins—typically low-complexity, Ser/Thr/Pro- and acidic/Gln-rich regulatory tails immediately after Met1; in single-pass membrane proteins, this extends to the first N‑terminal signal‑anchor/transmembrane helix. Overall, the feature marks the positional context of the protein’s N-terminus rather than a specific functional motif. | -0.77 | 3.31 | 4.08 | 18 | 45 |
| #6877 | First N-terminal secondary element | Short N-terminal segments at or just after the protein's N-terminus—covering the first secondary structure element of mature chains, often the first β-strand or α-helix—typically with mixed hydrophobic and polar/basic residues, across diverse taxa and functions. | -0.76 | 2.52 | 3.28 | 4 | 10 |
| #10784 | Thg1 catalytic core helices | Internal alpha-helices of the tRNA(His) guanylyltransferase (Thg1) catalytic core, with two main activating helices per protein at conserved positions. | +0.71 | 5.80 | 5.09 | 4 | 5 |
| #3392 | Amphipathic interface alpha helices | Generic solvent‑exposed, charged/amphipathic alpha‑helical segments that serve as macromolecular interface scaffolds (protein–protein and nucleic‑acid–binding helices), rather than catalytic residues; a broadly used structural motif across taxa | +0.69 | 6.50 | 5.82 | 5 | 7 |
| #8491 | IDRs with MoRF-like helices | Low-complexity, interaction-prone regions: intrinsically disordered segments and adjacent simple alpha-helical stretches (MoRF-/coiled-coil–like), enriched in polar/charged residues (Ser/Thr/Gln/Pro/Gly with acidic/basic clusters), used as activation domains, flexible linkers, or assembly interfaces. | -0.67 | 2.93 | 3.60 | 45 | 61 |
| #2302 | Seipin post-TM lumenal/propeptide detector | Detector of post-transmembrane lumenal segments in ER membrane proteins of the seipin family, with additional activation on the propeptide regions of TGF-β superfamily precursors (e.g., GDF-10/BMP-3B). | -0.66 | 6.52 | 7.18 | 24 | 54 |
| #13745 | Hydrophobic secondary structure signal | Generic hydrophobic secondary-structure signal: activates on hydrophobic/aromatic side chains that form stable α-helices and β-strands—covering transmembrane helices, coiled-coils, and the hydrophobic cores of globular domains—while avoiding catalytic/metal-binding residues and disordered segments | +0.62 | 9.59 | 8.96 | 30 | 33 |
| #14534 | Unknown generic feature | Unknown generic feature | -8.00 | 10.72 | 18.72 | 166 | 196 |
| #9194 | Unknown generic feature | Unknown generic feature | -3.42 | 10.82 | 14.24 | 168 | 198 |
| #14895 | Unknown generic feature | Unknown generic feature | -3.05 | 18.03 | 21.08 | 174 | 204 |
| #9214 | Unknown generic feature | Unknown generic feature | -2.62 | 14.34 | 16.95 | 170 | 200 |
| #9005 | Unknown generic feature | Unknown generic feature | -2.27 | 9.70 | 11.98 | 131 | 156 |
| #1803 | Unknown generic feature | Unknown generic feature | -1.88 | 14.27 | 16.14 | 165 | 196 |
Part 2 · Differential coordinates
Features firing on just the canonical-lost (truncated) residues.
Unique-region features — 193 distinct (prevalence ≥ 2)
| Feature | Label | Description | Activation | Prevalence |
|---|---|---|---|---|
| #4485 | Hydrophobic alpha-helical segments | Hydrophobic alpha-helical segments in soluble globular proteins, prominently a conserved helix near the active site of glycoside hydrolase family 27 alpha-galactosidases. | 17.47 | 28 |
| #1136 | Broad HORMA-domain activation N-terminal peak | HORMA-domain meiotic/checkpoint proteins, with activation distributed across the folded HORMA domain itself. | 10.03 | 31 |
| #14394 | Leu-rich hydrophobic alpha-helices | Generic hydrophobic, helix‑prone segments enriched in Leu/Val/Ile (and other aliphatic/aromatic residues) — covering short amphipathic helices within intrinsically disordered regions and juxtamembrane tails, as well as more stably folded hydrophobic helices (including transmembrane/coiled‑coil–like stretches). | 9.65 | 2 |
| #5707 | INRE-like short charged blocks | Short internal sequence blocks with a recurring (I/L)-N-R-E-(P/I)-F–like motif and surrounding charged residues, found in cobalamin-dependent isomerases and in other diverse bacterial/archaeal proteins | 8.95 | 15 |
| #11660 | Short hydrophobic helical patches | Short, Φ-rich (hydrophobic/aromatic) sequence segments, typically helix-like patches. Most often these correspond to the h-region of signal peptides or single-pass membrane anchors in secreted/periplasmic proteins, but the feature also fires on short internal helices or aromatic hydrophobic binding patches within soluble enzymes and structural proteins. | 8.62 | 13 |
| #14027 | Arg-rich linker and Walker A | Disordered linker segments of AAA+ initiator/replication proteins, with strong activation on a conserved Arg-rich motif in the unstructured region preceding the AAA+ ATPase domain, and weaker secondary activation on the Walker A/P-loop and nearby ATP-binding residues | 8.45 | 11 |
| #11911 | Short Lys/Arg-rich patches | Short sequence patches—often Lys/Arg-enriched and sometimes mixed with acidic residues—typically 8–25 residues long, frequently occurring in disordered N-terminal segments but also within ordered regions of diverse proteins, often associated with RNA/ribosome-contact surfaces or assembly interfaces. | 7.81 | 15 |
| #15815 | Basic N-terminal targeting patch | Short, basic/polar N‑terminal leader/transit segment immediately after the initiator methionine (positions ~3–6) — i.e., the positively charged/polar start of signal peptides and organelle transit peptides, and more generally low‑acidic, disordered N‑terminal patches (including occasional cysteine‑rich starts) used for targeting, export, rRNA binding, or membrane topology cues | 7.67 | 4 |
| #2302 | Seipin post-TM lumenal/propeptide detector | Detector of post-transmembrane lumenal segments in ER membrane proteins of the seipin family, with additional activation on the propeptide regions of TGF-β superfamily precursors (e.g., GDF-10/BMP-3B). | 7.18 | 31 |
| #13334 | N-terminal IDR boundary | Recognition of short, low-complexity, intrinsically disordered N-terminal tails immediately upstream of the first folded domain; these segments are often Ser/Thr/Pro/Gly/Ala-biased and sometimes extend a few residues into the initial helix or the very beginning of the first domain (domain boundary/disorder-to-order transition), especially in transcription regulators and co-regulators. | 6.64 | 27 |
| #16088 | Disordered mixed-charge linker patches | Short, mixed-charge, low-aromatic patches (rich in G/P/S/T/K/R/E/D) within intrinsically disordered regions, often at domain-flanking linkers of AAA+/P-loop ATPases and nucleic-acid–associated proteins. Marks generic polar/charged interaction or flexibility motifs rather than catalytic sites. | 6.52 | 10 |
| #220 | Phenylalanine-rich hydrophobic motif detector | Phenylalanine-focused residue identity feature: detects Phe (F) residues, with a preference for F-rich, hydrophobic stretches (e.g., signal peptides and transmembrane helices), but independent of secondary structure or specific function | 6.17 | 3 |
| #13449 | Membrane-biased alpha-helix detector | Generic alpha-helix detector with strongest preference for long hydrophobic helices that associate with membranes (transmembrane segments and signal peptides), but also activating on extended coiled-coils and internal alpha-helices in soluble proteins | 6.02 | 7 |
| #11633 | Assembly scaffold interaction modules | Protein–protein interaction modules in eukaryotic and bacterial assembly/scaffold proteins, prominently HORMA-domain folds and analogous α/β interaction cores, often adjoining low-complexity Ser/Thr/Pro- and Q/N-rich segments, mediating incorporation into large complexes (kinetochore, autophagy scaffolds, ER–mitochondria tethers, RNA-binding assemblies, dynein complexes, Hsp90 co-chaperone systems, COMMD-containing complexes). | 5.79 | 31 |
| #1949 | PMT FxRFLDxxQY helix | A conserved internal alpha-helical motif in plant/protist phosphoethanolamine N-methyltransferases (PMTs), centered on the sequence "FQRFLDNVQY" (and close variants). | 5.75 | 4 |
| #15283 | Short α-helical interface motifs | Short α-helical segments, often embedded in or adjacent to low-complexity regions. These helices frequently serve as oligomerization interfaces or membrane/scaffold docking elements in large assemblies and can also occur as generic interface/capping helices within soluble enzyme complexes. Peak residues commonly include hydrophobic and aromatic positions (F/M/L/W) alongside polar A/G/P/S/T/V and charged E/D/K/Q/R. | 5.64 | 25 |
| #7572 | Conserved catalytic helix motif | A conserved internal sequence/structural motif within enzyme catalytic domains, prominently exemplified by the "DRL(V/I)G(x)YEE" segment of the glutamate mutase epsilon subunit, where activation peaks on a short hydrophobic-aromatic stretch embedded in an α-helix close to cofactor/substrate binding residues. | 5.55 | 6 |
| #5114 | Short N-terminal targeting arm | N-terminal segments (typically the first ~10 residues) across a wide range of bacterial, viral, and eukaryotic proteins. These are often signal/targeting/assembly arms, including RNA/DNA-binding tails, secretion/chaperone-binding regions, and assembly linkers. | 5.43 | 14 |
| #9237 | Glycine detector in disordered regions | Residue-identity detector for glycine (G), with a mild bias toward intrinsically disordered/low-complexity segments (often including very N-terminal residues); pan-taxonomic and function-agnostic, but activation is sparse and frequently absent, becoming detectable mainly in glycine-rich low-complexity contexts; occasional weak responses to other small/polar residues. | 5.43 | 3 |
| #15338 | HECT E3 catalytic domain | The HECT catalytic domain of HECT-type E3 ubiquitin ligases, covering the C-terminal catalytic fold (including the catalytic cysteine forming the glycyl thioester intermediate) and extending broadly across the domain. | 5.28 | 31 |
| #1594 | Disordered tails, linkers, propeptides | Intrinsically disordered, low‑complexity linear regions (IDRs)—typically polar/charged and Ser/Thr/Pro/Gly‑rich—found most often at N‑terminal tails, cytosolic linkers, and propeptides; the feature avoids well‑folded domains but can extend into marginally structured, low‑complexity coiled‑coils or short amphipathic helices used as flexible tethers or assembly elements. | 5.27 | 31 |
| #3221 | N-terminal basic interaction tails | N-terminal, Lys/Arg- and Ser/Thr-rich interaction peptides: short, basic/polar, often amphipathic N-terminal segments (typically 20–80 aa) that serve as nucleic-acid–interacting tails or docking motifs for assembly with acidic protein complexes. | 5.17 | 19 |
| #10704 | N-terminal PEST-like IDRs | Low-complexity, often acidic/proline-rich intrinsically disordered N-terminal tails of intracellular eukaryotic proteins, frequently overlapping annotated PEST-like segments. | 5.10 | 9 |
| #7523 | Diffuse isoleucine composition bias | Weak global preference for isoleucine (and closely related aliphatic hydrophobes), captured primarily as a diffuse composition signal rather than discrete site recognition. | 5.07 | 4 |
| #14895 | Unknown generic feature | Unknown generic feature | 21.08 | 31 |
| #14534 | Unknown generic feature | Unknown generic feature | 18.72 | 31 |
| #9214 | Unknown generic feature | Unknown generic feature | 16.95 | 31 |
| #1803 | Unknown generic feature | Unknown generic feature | 16.14 | 31 |
| #9194 | Unknown generic feature | Unknown generic feature | 14.24 | 31 |
| #9005 | Unknown generic feature | Unknown generic feature | 11.98 | 25 |
Top-K sparse-autoencoder activations on the ESM-C residual stream. Activation is a feature's peak value over its region; Prevalence is the number of residues it fires on; Δ activation is isoform − canonical. Only the top 30 features per category are saved; generic / "unknown" features are hidden until you expand a table. Read more about SAE features →
Clinical variants
Differential region — lost N-terminus (canonical-only)
| Pos (iso) | AA change | Consequence | Source | Clin. sig. | AF (gnomAD) | Impact | AlphaMissense | ESM-C ΔLLR | Link |
|---|---|---|---|---|---|---|---|---|---|
| — | I→I | intronic | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120065808-G-A |
| — | I→F | intronic | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.85) | -11.62 | chr4-120065810-T-A |
| — | G→G | intronic | gnomAD | — | 3.63e-05 | — | — | 0.00 | chr4-120065811-G-A |
| — | G→D | intronic | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (1.00) | -12.62 | chr4-120065812-C-T |
| — | G→S | intronic | gnomAD | — | 2.05e-06 | damaging | likely_pathogenic (0.79) | -7.87 | chr4-120065813-C-T |
| — | F→F | intronic | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120065814-G-A |
| — | F→L | intronic | gnomAD | — | 8.90e-06 | damaging | likely_pathogenic (0.99) | -8.68 | chr4-120065814-G-C |
| — | S→S | intronic | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120065817-T-A |
| — | S→A | intronic | gnomAD | — | 1.38e-06 | damaging | likely_benign (0.10) | -7.52 | chr4-120066662-A-C |
| — | — | intronic | gnomAD | — | 2.07e-06 | damaging | — | — | chr4-120066662-AG-A |
| — | F→F | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066663-G-A |
| — | F→S | intronic | gnomAD | — | 2.07e-06 | damaging | likely_pathogenic (0.99) | -14.12 | chr4-120066664-A-G |
| — | F→L | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (1.00) | -10.12 | chr4-120066668-A-G |
| — | E→E | intronic | gnomAD | — | 8.27e-06 | — | — | 0.00 | chr4-120066669-C-T |
| — | A→A | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066672-G-A |
| — | A→T | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.67) | -7.68 | chr4-120066674-C-T |
| — | V→A | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.96) | -10.94 | chr4-120066676-A-G |
| — | V→L | intronic | gnomAD | — | 2.07e-06 | damaging | likely_pathogenic (0.97) | -11.31 | chr4-120066677-C-G |
| — | I→M | intronic | gnomAD | — | 1.38e-06 | — | likely_benign (0.16) | -7.18 | chr4-120066678-G-C |
| — | I→I | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066678-G-T |
| — | E→K | intronic | gnomAD | — | 1.38e-06 | damaging | likely_pathogenic (0.68) | -9.80 | chr4-120066683-C-T |
| — | A→A | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066684-G-C |
| — | A→A | intronic | gnomAD | — | 1.38e-06 | — | — | 0.00 | chr4-120066684-G-T |
| — | A→V | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.92) | -8.25 | chr4-120066685-G-A |
| — | A→S | intronic | gnomAD | — | 6.89e-07 | — | likely_benign (0.29) | -7.50 | chr4-120066686-C-A |
| — | A→T | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.78) | -7.62 | chr4-120066686-C-T |
| — | G→G | intronic | gnomAD | — | 2.75e-06 | — | — | 0.00 | chr4-120066690-C-G |
| — | G→G | intronic | gnomAD | — | 1.24e-05 | — | — | 0.00 | chr4-120066690-C-T |
| — | G→R | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (1.00) | -10.12 | chr4-120066692-C-G |
| — | R→R | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066693-G-T |
| — | L→P | intronic | gnomAD | — | 8.95e-06 | damaging | likely_pathogenic (0.99) | -11.44 | chr4-120066697-A-G |
| — | L→M | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.81) | -12.94 | chr4-120066698-G-T |
| — | T→T | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066699-G-A |
| — | I→M | intronic | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.80) | -10.37 | chr4-120066702-G-C |
| — | I→T | intronic | gnomAD | — | 1.38e-06 | damaging | likely_pathogenic (0.98) | -10.87 | chr4-120066703-A-G |
| — | I→V | intronic | gnomAD | — | 6.89e-06 | — | likely_benign (0.28) | -7.12 | chr4-120066704-T-C |
| — | G→G | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066705-T-C |
| — | G→R | intronic | gnomAD | — | 2.76e-06 | damaging | likely_pathogenic (0.89) | -8.56 | chr4-120066707-C-T |
| — | Q→Q | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066708-C-T |
| — | E→E | intronic | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120066711-C-T |
| — | E→V | intronic | gnomAD | — | 6.89e-07 | damaging | likely_benign (0.32) | -9.29 | chr4-120066712-T-A |
| — | — | intronic | gnomAD | — | 6.90e-07 | damaging | — | — | chr4-120066712-TC-T |
| — | E→K | intronic | gnomAD | — | 4.83e-06 | damaging | ambiguous (0.44) | -8.23 | chr4-120066713-C-T |
| — | R→R | intronic | gnomAD | — | 4.83e-06 | — | — | 0.00 | chr4-120066714-C-T |
| — | R→Q | intronic | gnomAD | — | 2.21e-05 | — | likely_benign (0.17) | -6.23 | chr4-120066715-C-T |
| — | R→W | intronic | gnomAD | — | 6.90e-07 | damaging | ambiguous (0.52) | -8.23 | chr4-120066716-G-A |
| — | R→G | intronic | gnomAD | — | 1.24e-05 | — | likely_benign (0.12) | -6.55 | chr4-120066716-G-C |
| — | S→F | intronic | gnomAD | — | 6.90e-07 | damaging | ambiguous (0.34) | -8.62 | chr4-120066718-G-A |
| — | L→L | intronic | gnomAD | — | 1.38e-06 | — | — | 0.00 | chr4-120066720-G-A |
| — | L→L | intronic | gnomAD | — | 1.38e-06 | — | — | 0.00 | chr4-120066720-G-C |
| — | L→H | intronic | gnomAD | — | 1.38e-06 | damaging | likely_benign (0.14) | -8.68 | chr4-120066721-A-T |
| — | L→F | intronic | gnomAD | — | 3.45e-06 | — | likely_benign (0.11) | -6.81 | chr4-120066722-G-A |
| — | L→V | intronic | gnomAD | — | 1.38e-06 | — | likely_benign (0.06) | -6.46 | chr4-120066722-G-C |
| — | L→I | intronic | gnomAD | — | 2.07e-06 | — | likely_benign (0.07) | -6.90 | chr4-120066722-G-T |
| — | Q→* | intronic | gnomAD | — | 1.38e-06 | damaging | — | — | chr4-120066725-G-A |
| — | L→L | intronic | gnomAD | — | 6.90e-07 | — | — | 0.00 | chr4-120066726-C-T |
| — | A→A | intronic | gnomAD | — | 1.38e-06 | — | — | 0.00 | chr4-120066729-C-T |
| — | A→V | intronic | gnomAD | — | 1.11e-05 | damaging | likely_pathogenic (0.60) | -7.98 | chr4-120066730-G-A |
| — | A→E | intronic | gnomAD | — | 6.92e-07 | damaging | ambiguous (0.34) | -8.11 | chr4-120066730-G-T |
| — | A→S | intronic | gnomAD | — | 6.91e-07 | — | likely_benign (0.13) | -5.20 | chr4-120066731-C-A |
| — | A→T | intronic | gnomAD | — | 1.73e-05 | — | likely_benign (0.33) | -5.05 | chr4-120066731-C-T |
| — | M→T | intronic | gnomAD | — | 1.38e-06 | damaging | — | -9.37 | chr4-120066733-A-G |
| — | M→K | intronic | gnomAD | — | 6.92e-07 | damaging | — | -10.81 | chr4-120066733-A-T |
| — | M→V | intronic | gnomAD | — | 6.92e-07 | damaging | — | -8.87 | chr4-120066734-T-C |
| — | G→R | intronic | ClinVar | Uncertain significance | — | damaging | likely_pathogenic (0.89) | -8.56 | ClinVar:2481387 |
| — | I→V | intronic | ClinVar | Uncertain significance | — | — | likely_benign (0.28) | -7.12 | ClinVar:2490789 |
| — | E→E | intronic | ClinVar | Likely benign | — | — | — | 0.00 | ClinVar:2655056 |
| — | L→L | intronic | ClinVar | Likely benign | — | — | — | 0.00 | ClinVar:2655057 |
| — | G→G | intronic | ClinVar | Likely benign | — | — | — | 0.00 | ClinVar:2655058 |
| — | Q→Q | intronic | ClinVar | Likely benign | — | — | — | 0.00 | ClinVar:2655059 |
| — | R→Q | intronic | ClinVar | Uncertain significance | — | — | likely_benign (0.17) | -6.23 | ClinVar:3541916 |
| — | G→G | intronic | COSMIC | — | — | — | — | 0.00 | COSV56636895 |
| — | S→L | intronic | COSMIC | — | — | damaging | likely_benign (0.27) | -8.56 | COSV56637555 |
| — | F→F | intronic | COSMIC | — | — | — | — | 0.00 | COSV56636758 |
| — | F→L | intronic | COSMIC | — | — | damaging | likely_pathogenic (1.00) | -10.12 | COSV56636790 |
| — | E→D | intronic | COSMIC | — | — | — | ambiguous (0.48) | -7.37 | COSV99633714 |
| — | A→V | intronic | COSMIC | — | — | damaging | likely_pathogenic (0.90) | -8.81 | COSV56637607 |
| — | G→R | intronic | COSMIC | — | — | damaging | likely_pathogenic (1.00) | -10.12 | COSV56637063 |
| — | L→M | intronic | COSMIC | — | — | damaging | likely_pathogenic (0.81) | -12.94 | COSV99633896 |
| — | I→I | intronic | COSMIC | — | — | — | — | 0.00 | COSV106426012 |
| — | I→N | intronic | COSMIC | — | — | damaging | likely_pathogenic (0.98) | -12.25 | COSV56636743 |
| — | Q→* | intronic | COSMIC | — | — | damaging | — | — | COSV56636507 |
| — | L→L | intronic | COSMIC | — | — | — | — | 0.00 | COSV56637843 |
| — | L→R | intronic | COSMIC | — | — | — | likely_benign (0.05) | -7.25 | COSV99633902 |
| — | — | intronic | COSMIC | — | — | damaging | — | — | COSV99634044 |
85 variants in the differential region.
Shared canonical core — sequence common to canonical and isoform; AlphaMissense applies here
| Pos (iso) | AA change | Consequence | Source | Clin. sig. | AF (gnomAD) | Impact | AlphaMissense | ESM-C ΔLLR | Link |
|---|---|---|---|---|---|---|---|---|---|
| 1 | L→L | synonymous_variant | gnomAD | — | 1.57e-05 | — | — | 0.00 | chr4-120065796-T-C |
| 2 | Y→* | stop_gained | gnomAD | — | 6.84e-07 | LoF | — | — | chr4-120065793-A-T |
| 2 | Y→H | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.96) | -8.81 | chr4-120065795-A-G |
| 4 | R→H | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.99) | -11.31 | chr4-120065788-C-T |
| 4 | R→C | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.99) | -11.44 | COSV56636453 |
| 5 | G→G | synonymous_variant | gnomAD | — | 2.05e-06 | — | — | 0.00 | chr4-120065784-G-C |
| 6 | I→M | missense_variant | gnomAD | — | 2.05e-06 | damaging | likely_pathogenic (0.67) | -8.43 | chr4-120065781-T-C |
| 6 | I→V | missense_variant | gnomAD | — | 6.84e-07 | — | likely_benign (0.13) | -6.25 | chr4-120065783-T-C |
| 6 | I→L | missense_variant | gnomAD | — | 6.84e-07 | — | likely_benign (0.23) | -7.18 | chr4-120065783-T-G |
| 6 | I→M | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.67) | -8.43 | COSV56637152 |
| 7 | Y→S | missense_variant | gnomAD | — | 2.05e-06 | damaging | likely_pathogenic (0.96) | -12.62 | chr4-120065779-T-G |
| 7 | Y→C | missense_variant | ClinVar | Uncertain significance | — | damaging | likely_pathogenic (0.91) | -12.06 | ClinVar:2337132 |
| 8 | P→P | synonymous_variant | gnomAD | — | 6.84e-07 | — | — | 0.00 | chr4-120065775-T-C |
| 9 | S→S | synonymous_variant | gnomAD | — | 6.84e-06 | — | — | 0.00 | chr4-120065772-A-T |
| 9 | S→C | missense_variant | gnomAD | — | 2.05e-06 | damaging | likely_benign (0.15) | -9.02 | chr4-120065773-G-C |
| 11 | T→T | synonymous_variant | gnomAD | — | 2.05e-06 | — | — | 0.00 | chr4-120065766-G-A |
| 11 | T→N | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_benign (0.16) | -8.18 | chr4-120065767-G-T |
| 13 | T→I | missense_variant | gnomAD | — | 3.42e-06 | — | likely_benign (0.26) | -6.92 | chr4-120065761-G-A |
| 13 | T→I | missense_variant | ClinVar | Uncertain significance | — | — | likely_benign (0.26) | -6.92 | ClinVar:2314971 |
| 14 | R→G | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.82) | -9.50 | chr4-120065759-G-C |
| 14 | R→R | synonymous_variant | gnomAD | — | 6.84e-07 | — | — | 0.00 | chr4-120065759-G-T |
| 14 | R→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56636783 |
| 15 | V→V | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120065754-C-T |
| 15 | V→A | missense_variant | gnomAD | — | 6.84e-07 | — | ambiguous (0.39) | -5.87 | chr4-120065755-A-G |
| 16 | Q→P | missense_variant | gnomAD | — | 2.05e-06 | damaging | likely_benign (0.27) | -8.50 | chr4-120065752-T-G |
| 16 | Q→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV99634048 |
| 16 | Q→Q | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56636984 |
| 16 | Q→R | missense_variant | COSMIC | — | — | damaging | likely_benign (0.32) | -9.25 | COSV105896543 |
| 17 | K→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56636610 |
| 18 | Y→Y | synonymous_variant | gnomAD | — | 4.31e-05 | — | — | 0.00 | chr4-120065745-G-A |
| 18 | Y→C | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.98) | -9.81 | COSV56636603 |
| 19 | G→R | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.97) | -10.25 | COSV106426007 |
| 19 | G→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56636827 |
| 20 | L→F | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.91) | -9.62 | chr4-120065741-G-A |
| 21 | T→T | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120065736-G-A |
| 21 | T→T | synonymous_variant | gnomAD | — | 6.84e-07 | — | — | 0.00 | chr4-120065736-G-C |
| 21 | T→I | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.77) | -8.68 | chr4-120065737-G-A |
| 22 | L→F | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.77) | -9.87 | chr4-120065733-C-G |
| 22 | — | frameshift_variant | gnomAD | — | 8.21e-06 | LoF | — | — | chr4-120065733-CA-C |
| 22 | L→W | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.98) | -13.31 | chr4-120065734-A-C |
| 23 | L→F | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_benign (0.26) | -8.69 | chr4-120065732-G-A |
| 24 | V→L | missense_variant | COSMIC | — | — | — | likely_benign (0.32) | -7.34 | COSV56636970 |
| 26 | T→A | missense_variant | gnomAD | — | 2.12e-05 | — | likely_benign (0.10) | -5.80 | chr4-120065723-T-C |
| 29 | E→Q | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_benign (0.13) | -7.58 | chr4-120065714-C-G |
| 31 | — | frameshift_variant | gnomAD | — | 6.84e-07 | LoF | — | — | chr4-120065708-TG-T |
| 32 | K→R | missense_variant | gnomAD | — | 6.84e-07 | — | likely_benign (0.08) | -5.92 | chr4-120065704-T-C |
| 32 | K→* | stop_gained | gnomAD | — | 6.84e-07 | LoF | — | — | chr4-120065705-T-A |
| 33 | Y→F | missense_variant | gnomAD | — | 2.74e-06 | — | ambiguous (0.38) | -6.94 | chr4-120065701-T-A |
| 33 | Y→C | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.96) | -10.00 | chr4-120065701-T-C |
| 33 | Y→N | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.98) | -10.81 | COSV99633708 |
| 34 | L→L | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120065697-T-C |
| 34 | L→L | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120065697-T-G |
| 34 | — | frameshift_variant | gnomAD | — | 6.84e-07 | LoF | — | — | chr4-120065697-TA-T |
| 34 | L→I | missense_variant | gnomAD | — | 1.21e-04 | damaging | likely_benign (0.17) | -8.31 | chr4-120065699-G-T |
| 35 | N→S | missense_variant | gnomAD | — | 2.74e-06 | — | likely_benign (0.07) | -3.68 | chr4-120065695-T-C |
| 35 | N→N | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV108109490 |
| 36 | N→N | synonymous_variant | gnomAD | — | 2.05e-06 | — | — | 0.00 | chr4-120065691-A-G |
| 36 | N→Y | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_benign (0.16) | -8.23 | chr4-120065693-T-A |
| 36 | N→Y | missense_variant | ClinVar | Uncertain significance | — | damaging | likely_benign (0.16) | -8.23 | ClinVar:3869470 |
| 37 | V→G | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (0.89) | -11.56 | chr4-120065689-A-C |
| 37 | V→L | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.88) | -8.69 | chr4-120065690-C-A |
| 39 | E→K | missense_variant | COSMIC | — | — | damaging | likely_benign (0.14) | -7.81 | COSV56636425 |
| 40 | Q→Q | synonymous_variant | gnomAD | — | 1.57e-05 | — | — | 0.00 | chr4-120065679-T-C |
| 41 | L→L | synonymous_variant | gnomAD | — | 4.11e-06 | — | — | 0.00 | chr4-120065676-C-T |
| 42 | K→R | missense_variant | gnomAD | — | 6.84e-07 | — | likely_benign (0.10) | -4.08 | chr4-120065674-T-C |
| 43 | D→G | missense_variant | gnomAD | — | 6.88e-07 | — | likely_benign (0.12) | -5.71 | chr4-120062095-T-C |
| 43 | D→H | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_benign (0.28) | -9.40 | chr4-120065672-C-G |
| 44 | W→L | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.93) | -10.50 | COSV99633853 |
| 45 | L→L | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120062088-T-C |
| 45 | — | frameshift_variant | gnomAD | — | 6.18e-06 | LoF | — | — | chr4-120062090-A-AC |
| 46 | Y→C | missense_variant | gnomAD | — | 2.74e-06 | — | likely_benign (0.07) | -5.45 | chr4-120062086-T-C |
| 46 | Y→F | missense_variant | COSMIC | — | — | — | likely_benign (0.08) | -4.57 | COSV56636540 |
| 46 | Y→H | missense_variant | COSMIC | — | — | — | likely_benign (0.13) | -6.64 | COSV56637585 |
| 47 | K→N | missense_variant | gnomAD | — | 1.51e-05 | — | likely_benign (0.19) | -6.30 | chr4-120062082-C-G |
| 47 | K→K | synonymous_variant | gnomAD | — | 3.43e-06 | — | — | 0.00 | chr4-120062082-C-T |
| 47 | K→R | missense_variant | gnomAD | — | 1.23e-05 | — | likely_benign (0.07) | -5.96 | chr4-120062083-T-C |
| 47 | K→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56637871 |
| 48 | C→Y | missense_variant | gnomAD | — | 1.37e-06 | damaging | ambiguous (0.51) | -8.62 | chr4-120062080-C-T |
| 48 | C→S | missense_variant | gnomAD | — | 2.06e-06 | — | ambiguous (0.41) | -7.19 | chr4-120062081-A-T |
| 49 | S→S | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120062076-T-A |
| 49 | S→S | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120062076-T-C |
| 49 | S→L | missense_variant | gnomAD | — | 6.85e-07 | — | likely_benign (0.10) | -6.53 | chr4-120062077-G-A |
| 49 | S→* | stop_gained | gnomAD | — | 6.85e-07 | LoF | — | — | chr4-120062077-G-C |
| 49 | S→L | missense_variant | COSMIC | — | — | — | likely_benign (0.10) | -6.53 | COSV56636668 |
| 51 | Q→R | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_benign (0.32) | -8.62 | chr4-120062071-T-C |
| 51 | Q→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56636702 |
| 53 | L→L | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120062064-C-A |
| 53 | L→L | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637689 |
| 54 | V→V | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120062061-A-T |
| 54 | V→F | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.99) | -12.31 | chr4-120062063-C-A |
| 55 | V→L | missense_variant | gnomAD | — | 6.85e-07 | — | likely_benign (0.27) | -7.25 | chr4-120062060-C-G |
| 55 | V→G | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.92) | -11.81 | COSV106426017 |
| 56 | V→V | synonymous_variant | gnomAD | — | 4.79e-06 | — | — | 0.00 | chr4-120062055-A-G |
| 56 | V→I | missense_variant | gnomAD | — | 6.16e-06 | damaging | likely_benign (0.22) | -8.50 | chr4-120062057-C-T |
| 57 | I→I | synonymous_variant | gnomAD | — | 4.11e-06 | — | — | 0.00 | chr4-120062052-G-A |
| 57 | I→T | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.98) | -8.56 | chr4-120062053-A-G |
| 59 | N→D | missense_variant | gnomAD | — | 6.16e-06 | — | likely_benign (0.07) | -6.80 | chr4-120062048-T-C |
| 59 | N→D | missense_variant | ClinVar | Uncertain significance | — | — | likely_benign (0.07) | -6.80 | ClinVar:3121965 |
| 60 | I→V | missense_variant | gnomAD | — | 6.09e-05 | — | likely_benign (0.06) | -4.88 | chr4-120062045-T-C |
| 60 | I→N | missense_variant | COSMIC | — | — | damaging | likely_benign (0.31) | -8.57 | COSV56636977 |
| 60 | I→V | missense_variant | COSMIC | — | — | — | likely_benign (0.06) | -4.88 | COSV99047961 |
| 62 | S→R | missense_variant | gnomAD | — | 6.85e-07 | damaging | ambiguous (0.48) | -9.10 | chr4-120062037-A-C |
| 62 | S→S | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120062037-A-G |
| 62 | S→T | missense_variant | gnomAD | — | 6.85e-07 | — | likely_benign (0.06) | -3.75 | chr4-120062038-C-G |
| 62 | S→N | missense_variant | gnomAD | — | 1.16e-05 | — | likely_benign (0.07) | -5.35 | chr4-120062038-C-T |
| 62 | S→R | missense_variant | COSMIC | — | — | damaging | ambiguous (0.48) | -9.10 | COSV56636802 |
| 63 | G→V | missense_variant | gnomAD | — | 6.85e-07 | damaging | ambiguous (0.40) | -10.24 | chr4-120062035-C-A |
| 63 | G→D | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_benign (0.21) | -8.74 | chr4-120062035-C-T |
| 64 | E→K | missense_variant | gnomAD | — | 1.44e-05 | damaging | likely_benign (0.33) | -9.75 | chr4-120062033-C-T |
| 64 | E→K | missense_variant | COSMIC | — | — | damaging | likely_benign (0.33) | -9.75 | COSV105174397 |
| 65 | V→V | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120062028-G-A |
| 66 | L→L | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120062025-C-T |
| 66 | L→V | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_benign (0.15) | -8.75 | chr4-120062027-G-C |
| 68 | R→I | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.99) | -13.75 | chr4-120062020-C-A |
| 70 | Q→R | missense_variant | gnomAD | — | 2.74e-06 | damaging | likely_pathogenic (0.85) | -10.81 | chr4-120062014-T-C |
| 70 | Q→P | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.99) | -12.12 | chr4-120062014-T-G |
| 71 | F→L | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (1.00) | -10.44 | chr4-120062012-A-G |
| 72 | D→V | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.81) | -10.75 | chr4-120062008-T-A |
| 72 | D→N | missense_variant | COSMIC | — | — | damaging | ambiguous (0.38) | -9.00 | COSV109419265 |
| 73 | I→I | synonymous_variant | gnomAD | — | 4.11e-06 | — | — | 0.00 | chr4-120062004-A-T |
| 73 | I→T | missense_variant | gnomAD | — | 3.42e-06 | damaging | likely_pathogenic (0.79) | -9.06 | chr4-120062005-A-G |
| 74 | E→Q | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_benign (0.18) | -7.62 | chr4-120062003-C-G |
| 75 | C→Y | missense_variant | gnomAD | — | 2.74e-06 | damaging | likely_pathogenic (0.82) | -9.50 | chr4-120061999-C-T |
| 76 | D→E | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (0.61) | -8.56 | chr4-120061995-G-C |
| 77 | K→M | missense_variant | COSMIC | — | — | damaging | ambiguous (0.41) | -9.25 | COSV56637840 |
| 78 | T→T | synonymous_variant | gnomAD | — | 1.24e-05 | — | — | 0.00 | chr4-120061989-A-G |
| 78 | T→T | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637816 |
| 79 | A→A | synonymous_variant | gnomAD | — | 6.88e-07 | — | — | 0.00 | chr4-120061986-T-G |
| 79 | A→V | missense_variant | gnomAD | — | 6.89e-07 | — | likely_benign (0.10) | -5.11 | chr4-120061987-G-A |
| 79 | A→S | missense_variant | gnomAD | — | 2.07e-06 | — | likely_benign (0.12) | -7.11 | chr4-120061988-C-A |
| 79 | A→V | missense_variant | COSMIC | — | — | — | likely_benign (0.10) | -5.11 | COSV56636463 |
| 80 | K→E | missense_variant | gnomAD | — | 1.38e-06 | damaging | likely_benign (0.13) | -7.83 | chr4-120061985-T-C |
| 81 | D→D | synonymous_variant | gnomAD | — | 6.90e-07 | — | — | 0.00 | chr4-120061980-A-G |
| 81 | D→Y | missense_variant | gnomAD | — | 3.45e-06 | damaging | likely_benign (0.26) | -8.36 | chr4-120061982-C-A |
| 82 | D→Y | missense_variant | gnomAD | — | 6.90e-07 | damaging | likely_benign (0.19) | -7.57 | chr4-120061979-C-A |
| 83 | S→S | synonymous_variant | gnomAD | — | 5.60e-06 | — | — | 0.00 | chr4-120060977-A-G |
| 83 | S→I | missense_variant | ClinVar | — | — | damaging | likely_benign (0.15) | -7.89 | ClinVar:4301842 |
| 83 | S→N | missense_variant | COSMIC | — | — | — | likely_benign (0.12) | -5.11 | COSV105174411 |
| 84 | A→A | synonymous_variant | gnomAD | — | 1.39e-06 | — | — | 0.00 | chr4-120060974-T-C |
| 84 | A→V | missense_variant | gnomAD | — | 2.79e-06 | — | likely_benign (0.07) | -3.28 | chr4-120060975-G-A |
| 84 | A→A | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56636648 |
| 85 | P→L | missense_variant | gnomAD | — | 2.08e-06 | — | likely_benign (0.25) | -6.75 | chr4-120060972-G-A |
| 85 | P→A | missense_variant | gnomAD | — | 1.39e-06 | damaging | likely_benign (0.13) | -7.56 | chr4-120060973-G-C |
| 85 | P→T | missense_variant | COSMIC | — | — | damaging | likely_benign (0.21) | -7.84 | COSV99633915 |
| 86 | R→S | missense_variant | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.92) | -8.87 | chr4-120060968-T-A |
| 86 | R→I | missense_variant | gnomAD | — | 6.92e-07 | damaging | likely_pathogenic (0.76) | -10.80 | chr4-120060969-C-A |
| 86 | R→G | missense_variant | gnomAD | — | 2.07e-06 | damaging | likely_pathogenic (0.70) | -7.90 | chr4-120060970-T-C |
| 88 | K→K | synonymous_variant | gnomAD | — | 6.87e-07 | — | — | 0.00 | chr4-120060962-C-T |
| 88 | — | frameshift_variant | gnomAD | — | 6.87e-07 | LoF | — | — | chr4-120060962-CT-C |
| 88 | K→M | missense_variant | gnomAD | — | 1.99e-05 | damaging | likely_pathogenic (0.82) | -10.31 | chr4-120060963-T-A |
| 88 | K→E | missense_variant | gnomAD | — | 6.88e-07 | damaging | likely_pathogenic (0.96) | -11.06 | chr4-120060964-T-C |
| 89 | S→S | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120060959-A-G |
| 89 | S→F | missense_variant | gnomAD | — | 5.70e-05 | damaging | likely_pathogenic (0.80) | -9.05 | chr4-120060960-G-A |
| 89 | S→C | missense_variant | gnomAD | — | 1.37e-06 | — | likely_benign (0.21) | -7.18 | chr4-120060960-G-C |
| 89 | S→C | missense_variant | ClinVar | Uncertain significance | — | — | likely_benign (0.21) | -7.18 | ClinVar:2624283 |
| 90 | Q→H | missense_variant | gnomAD | — | 2.06e-06 | — | likely_benign (0.21) | -6.53 | chr4-120060956-C-G |
| 90 | Q→P | missense_variant | gnomAD | — | 3.29e-05 | — | likely_benign (0.10) | -7.21 | chr4-120060957-T-G |
| 91 | K→K | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120060953-T-C |
| 91 | K→T | missense_variant | gnomAD | — | 6.86e-07 | damaging | ambiguous (0.37) | -8.37 | chr4-120060954-T-G |
| 91 | K→E | missense_variant | gnomAD | — | 6.86e-07 | damaging | ambiguous (0.42) | -7.78 | chr4-120060955-T-C |
| 94 | Q→R | missense_variant | gnomAD | — | 3.43e-06 | damaging | likely_benign (0.30) | -9.00 | chr4-120060945-T-C |
| 94 | Q→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV99633770 |
| 95 | D→N | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_benign (0.15) | -8.18 | chr4-120060943-C-T |
| 95 | D→N | missense_variant | ClinVar | Uncertain significance | — | damaging | likely_benign (0.15) | -8.18 | ClinVar:3121966 |
| 97 | I→V | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (0.65) | -9.37 | chr4-120060937-T-C |
| 97 | I→I | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637007 |
| 97 | I→V | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.65) | -9.37 | COSV56636872 |
| 98 | R→L | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (0.96) | -10.50 | chr4-120060933-C-A |
| 98 | R→H | missense_variant | gnomAD | — | 6.85e-06 | damaging | likely_pathogenic (0.74) | -8.75 | chr4-120060933-C-T |
| 98 | R→C | missense_variant | gnomAD | — | 3.43e-05 | damaging | likely_pathogenic (0.61) | -8.56 | chr4-120060934-G-A |
| 98 | R→G | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.86) | -10.06 | chr4-120060934-G-C |
| 98 | R→S | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.93) | -9.37 | chr4-120060934-G-T |
| 98 | R→C | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.61) | -8.56 | COSV99633932 |
| 99 | S→A | missense_variant | gnomAD | — | 6.85e-07 | — | likely_benign (0.12) | -6.47 | chr4-120060931-A-C |
| 99 | S→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56636444 |
| 100 | V→V | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060926-C-G |
| 101 | I→M | missense_variant | gnomAD | — | 8.22e-06 | damaging | likely_benign (0.27) | -8.94 | chr4-120060923-G-C |
| 102 | R→K | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.79) | -10.37 | COSV56637106 |
| 102 | R→T | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (1.00) | -13.44 | COSV56636656 |
| 103 | Q→Q | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637581 |
| 105 | T→T | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120060911-T-C |
| 105 | T→I | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.94) | -9.81 | COSV56637834 |
| 106 | A→A | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120060908-A-C |
| 106 | A→D | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (1.00) | -11.12 | COSV56637574 |
| 107 | T→T | synonymous_variant | gnomAD | — | 1.10e-05 | — | — | 0.00 | chr4-120060905-C-T |
| 107 | T→M | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (0.69) | -9.56 | chr4-120060906-G-A |
| 107 | T→T | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637199 |
| 107 | T→M | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.69) | -9.56 | COSV99633752 |
| 108 | V→V | synonymous_variant | gnomAD | — | 6.87e-07 | — | — | 0.00 | chr4-120060902-C-T |
| 108 | V→V | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56637231 |
| 108 | V→A | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.97) | -10.50 | COSV56637826 |
| 112 | P→P | synonymous_variant | gnomAD | — | 6.18e-02 | — | — | 0.00 | chr4-120060890-T-C |
| 112 | P→L | missense_variant | gnomAD | — | 6.89e-07 | damaging | likely_pathogenic (0.99) | -11.69 | chr4-120060891-G-A |
| 112 | P→P | synonymous_variant | COSMIC | — | — | — | — | 0.00 | COSV56636944 |
| 113 | L→L | synonymous_variant | gnomAD | — | 6.89e-07 | — | — | 0.00 | chr4-120060887-C-G |
| 115 | E→D | missense_variant | COSMIC | — | — | — | likely_benign (0.09) | -6.00 | COSV56637746 |
| 115 | E→Q | missense_variant | COSMIC | — | — | damaging | likely_benign (0.34) | -8.68 | COSV56636515 |
| 116 | V→A | missense_variant | gnomAD | — | 6.91e-07 | — | likely_benign (0.09) | -3.35 | chr4-120060879-A-G |
| 116 | V→F | missense_variant | gnomAD | — | 6.91e-07 | damaging | likely_benign (0.17) | -8.22 | chr4-120060880-C-A |
| 117 | S→F | missense_variant | gnomAD | — | 6.92e-07 | damaging | likely_benign (0.33) | -8.87 | chr4-120060876-G-A |
| 117 | S→Y | missense_variant | gnomAD | — | 1.38e-06 | damaging | likely_benign (0.29) | -9.62 | chr4-120060876-G-T |
| 117 | — | frameshift_variant | gnomAD | — | 6.92e-07 | LoF | — | — | chr4-120060876-GA-G |
| 118 | C→Y | missense_variant | gnomAD | — | 3.45e-06 | damaging | likely_pathogenic (0.97) | -10.19 | chr4-120060290-C-T |
| 118 | C→Y | missense_variant | ClinVar | Uncertain significance | — | damaging | likely_pathogenic (0.97) | -10.19 | ClinVar:4050418 |
| 118 | C→R | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.98) | -11.37 | COSV56637100 |
| 119 | S→L | missense_variant | gnomAD | — | 6.88e-07 | damaging | ambiguous (0.39) | -9.55 | chr4-120060287-G-A |
| 119 | S→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV56637188 |
| 121 | D→E | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.91) | -8.31 | chr4-120060280-A-T |
| 121 | D→N | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.70) | -9.06 | COSV108814783 |
| 122 | L→L | synonymous_variant | gnomAD | — | 2.06e-06 | — | — | 0.00 | chr4-120060277-C-T |
| 122 | L→P | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (1.00) | -11.37 | chr4-120060278-A-G |
| 123 | L→L | synonymous_variant | gnomAD | — | 2.06e-05 | — | — | 0.00 | chr4-120060274-C-T |
| 123 | L→V | missense_variant | gnomAD | — | 2.06e-06 | damaging | likely_pathogenic (0.82) | -9.62 | chr4-120060276-G-C |
| 124 | — | frameshift_variant | COSMIC | — | — | LoF | — | — | COSV99633904 |
| 125 | Y→D | missense_variant | gnomAD | — | 6.86e-07 | damaging | likely_pathogenic (0.99) | -11.12 | chr4-120060270-A-C |
| 126 | T→I | missense_variant | gnomAD | — | 6.86e-07 | damaging | likely_pathogenic (0.96) | -6.87 | chr4-120060266-G-A |
| 126 | T→A | missense_variant | gnomAD | — | 6.85e-07 | — | ambiguous (0.36) | -6.75 | chr4-120060267-T-C |
| 126 | T→A | missense_variant | COSMIC | — | — | — | ambiguous (0.36) | -6.75 | COSV56637751 |
| 128 | — | frameshift_variant | gnomAD | — | 4.11e-06 | LoF | — | — | chr4-120060260-TTGTC-T |
| 129 | D→H | missense_variant | gnomAD | — | 4.11e-06 | damaging | likely_pathogenic (0.68) | -8.75 | chr4-120060258-C-G |
| 130 | L→F | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_benign (0.33) | -8.37 | chr4-120060253-C-G |
| 130 | L→S | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_benign (0.29) | -8.87 | chr4-120060254-A-G |
| 130 | L→M | missense_variant | gnomAD | — | 2.05e-06 | — | likely_benign (0.10) | -7.28 | chr4-120060255-A-T |
| 130 | L→F | missense_variant | COSMIC | — | — | damaging | likely_benign (0.33) | -8.37 | COSV99633667 |
| 130 | L→W | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.59) | -11.50 | COSV56636532 |
| 131 | V→V | synonymous_variant | gnomAD | — | 6.84e-07 | — | — | 0.00 | chr4-120060250-A-T |
| 131 | V→L | missense_variant | gnomAD | — | 7.53e-06 | — | likely_benign (0.11) | -5.09 | chr4-120060252-C-G |
| 132 | V→V | synonymous_variant | gnomAD | — | 4.79e-06 | — | — | 0.00 | chr4-120060247-T-C |
| 132 | V→L | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.61) | -8.00 | chr4-120060249-C-A |
| 134 | — | frameshift_variant | COSMIC | — | — | LoF | — | — | COSV56637918 |
| 134 | — | frameshift_variant | COSMIC | — | — | LoF | — | — | COSV56637019 |
| 134 | E→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV99633990 |
| 136 | W→S | missense_variant | gnomAD | — | 6.84e-07 | damaging | likely_pathogenic (1.00) | -12.37 | chr4-120060236-C-G |
| 136 | W→G | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.98) | -11.81 | COSV56637715 |
| 137 | E→K | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.75) | -9.25 | COSV99633670 |
| 138 | E→K | missense_variant | gnomAD | — | 2.74e-06 | damaging | likely_pathogenic (0.92) | -9.69 | chr4-120060231-C-T |
| 139 | S→S | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060226-C-A |
| 139 | S→S | synonymous_variant | gnomAD | — | 1.57e-05 | — | — | 0.00 | chr4-120060226-C-T |
| 139 | S→L | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.69) | -10.25 | COSV104613725 |
| 140 | G→E | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.89) | -9.12 | chr4-120060224-C-T |
| 141 | — | frameshift_variant | gnomAD | — | 6.85e-07 | LoF | — | — | chr4-120060220-TG-T |
| 141 | P→T | missense_variant | gnomAD | — | 9.58e-06 | damaging | likely_pathogenic (0.89) | -10.31 | chr4-120060222-G-T |
| 141 | P→T | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.89) | -10.31 | COSV56637625 |
| 143 | F→L | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.77) | -6.34 | chr4-120060216-A-G |
| 144 | I→I | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060211-A-T |
| 144 | I→V | missense_variant | gnomAD | — | 4.11e-06 | — | likely_benign (0.13) | -6.56 | chr4-120060213-T-C |
| 145 | T→T | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060208-G-A |
| 145 | T→T | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060208-G-C |
| 146 | N→N | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060205-A-G |
| 146 | N→S | missense_variant | gnomAD | — | 6.85e-07 | — | likely_benign (0.07) | -4.55 | chr4-120060206-T-C |
| 147 | S→F | missense_variant | gnomAD | — | 3.42e-06 | damaging | likely_pathogenic (0.85) | -10.37 | chr4-120060203-G-A |
| 147 | S→A | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_benign (0.10) | -9.31 | chr4-120060204-A-C |
| 147 | S→T | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_benign (0.33) | -10.69 | chr4-120060204-A-T |
| 148 | E→G | missense_variant | gnomAD | — | 1.51e-05 | damaging | likely_pathogenic (0.86) | -10.19 | chr4-120060200-T-C |
| 149 | E→G | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.73) | -9.69 | chr4-120060197-T-C |
| 149 | E→K | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.73) | -9.00 | chr4-120060198-C-T |
| 150 | V→I | missense_variant | gnomAD | — | 6.85e-07 | damaging | ambiguous (0.49) | -9.00 | chr4-120060195-C-T |
| 151 | R→L | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.76) | -8.18 | chr4-120060191-C-A |
| 151 | R→H | missense_variant | gnomAD | — | 7.53e-06 | — | likely_benign (0.32) | -6.15 | chr4-120060191-C-T |
| 151 | R→C | missense_variant | gnomAD | — | 1.64e-05 | — | ambiguous (0.44) | -6.15 | chr4-120060192-G-A |
| 151 | R→L | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.76) | -8.18 | COSV99633797 |
| 151 | R→C | missense_variant | COSMIC | — | — | — | ambiguous (0.44) | -6.15 | COSV56637784 |
| 152 | L→F | missense_variant | gnomAD | — | 1.10e-05 | damaging | likely_pathogenic (0.90) | -9.69 | chr4-120060189-G-A |
| 152 | L→R | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.99) | -13.06 | COSV99633921 |
| 153 | R→L | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.97) | -10.50 | chr4-120060185-C-A |
| 153 | R→H | missense_variant | gnomAD | — | 7.53e-06 | damaging | likely_pathogenic (0.71) | -8.25 | chr4-120060185-C-T |
| 153 | R→C | missense_variant | gnomAD | — | 2.74e-06 | damaging | likely_pathogenic (0.86) | -8.19 | chr4-120060186-G-A |
| 153 | R→H | missense_variant | ClinVar | Uncertain significance | — | damaging | likely_pathogenic (0.71) | -8.25 | ClinVar:3541917 |
| 153 | R→C | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.86) | -8.19 | COSV56637566 |
| 154 | S→S | synonymous_variant | gnomAD | — | 9.59e-06 | — | — | 0.00 | chr4-120060181-T-C |
| 154 | S→L | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.86) | -12.12 | chr4-120060182-G-A |
| 154 | S→* | stop_gained | COSMIC | — | — | LoF | — | — | COSV99633830 |
| 155 | F→F | synonymous_variant | gnomAD | — | 6.85e-07 | — | — | 0.00 | chr4-120060178-A-G |
| 155 | F→L | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (1.00) | -9.62 | chr4-120060180-A-G |
| 158 | T→I | missense_variant | gnomAD | — | 6.85e-07 | damaging | likely_pathogenic (0.89) | -7.96 | chr4-120060170-G-A |
| 158 | T→I | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.89) | -7.96 | COSV106096082 |
| 159 | I→V | missense_variant | gnomAD | — | 5.62e-03 | — | likely_benign (0.10) | -5.18 | chr4-120060168-T-C |
| 159 | I→V | missense_variant | ClinVar | Benign | — | — | likely_benign (0.10) | -5.18 | ClinVar:782943 |
| 160 | H→H | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120060163-G-A |
| 160 | H→R | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (0.99) | -11.31 | COSV56637130 |
| 162 | V→V | synonymous_variant | gnomAD | — | 6.86e-07 | — | — | 0.00 | chr4-120060157-T-C |
| 163 | N→N | synonymous_variant | gnomAD | — | 1.37e-06 | — | — | 0.00 | chr4-120060154-A-G |
| 164 | S→N | missense_variant | gnomAD | — | 1.37e-06 | damaging | likely_pathogenic (0.93) | -10.75 | chr4-120060152-C-T |
| 164 | S→G | missense_variant | COSMIC | — | — | damaging | likely_benign (0.28) | -9.44 | COSV56636733 |
| 165 | M→K | missense_variant | gnomAD | — | 7.56e-06 | damaging | ambiguous (0.44) | -9.44 | chr4-120060149-A-T |
| 166 | V→M | missense_variant | COSMIC | — | — | damaging | likely_pathogenic (1.00) | -11.62 | COSV56636857 |
| 167 | A→A | synonymous_variant | gnomAD | — | 2.07e-06 | — | — | 0.00 | chr4-120060142-G-A |
| 167 | A→A | synonymous_variant | gnomAD | — | 6.91e-07 | — | — | 0.00 | chr4-120060142-G-C |
| 167 | A→V | missense_variant | gnomAD | — | 6.91e-07 | damaging | likely_pathogenic (0.78) | -8.25 | chr4-120060143-G-A |
| 167 | A→T | missense_variant | gnomAD | — | 2.07e-06 | — | ambiguous (0.42) | -6.56 | chr4-120060144-C-T |
| 168 | Y→Y | synonymous_variant | gnomAD | — | 6.90e-07 | — | — | 0.00 | chr4-120060139-G-A |
| 169 | K→R | missense_variant | gnomAD | — | 2.07e-06 | — | likely_benign (0.06) | -5.31 | chr4-120060137-T-C |
| 169 | K→E | missense_variant | gnomAD | — | 6.90e-07 | damaging | likely_pathogenic (0.69) | -11.37 | chr4-120060138-T-C |
| 170 | I→M | missense_variant | gnomAD | — | 2.07e-06 | — | likely_benign (0.09) | -6.84 | chr4-120060133-A-C |
| 170 | I→I | synonymous_variant | gnomAD | — | 6.90e-07 | — | — | 0.00 | chr4-120060133-A-G |
| 171 | P→S | missense_variant | COSMIC | — | — | — | likely_benign (0.13) | -5.24 | COSV56636813 |
| 172 | V→V | synonymous_variant | gnomAD | — | 6.91e-07 | — | — | 0.00 | chr4-120060127-G-A |
| 172 | V→L | missense_variant | gnomAD | — | 4.15e-06 | — | likely_benign (0.09) | -5.62 | chr4-120060129-C-G |
| 172 | V→I | missense_variant | gnomAD | — | 4.84e-06 | — | likely_benign (0.07) | -4.18 | chr4-120060129-C-T |
| 172 | V→I | missense_variant | COSMIC | — | — | — | likely_benign (0.07) | -4.18 | COSV56636962 |
| 173 | N→S | missense_variant | gnomAD | — | 1.38e-06 | — | likely_benign (0.06) | -3.94 | chr4-120060125-T-C |
| 174 | D→D | synonymous_variant | gnomAD | — | 1.38e-05 | — | — | 0.00 | chr4-120060121-G-A |
| 174 | D→Y | missense_variant | gnomAD | — | 1.38e-06 | damaging | likely_benign (0.28) | -7.90 | chr4-120060123-C-A |
| 174 | D→N | missense_variant | gnomAD | — | 2.77e-06 | — | likely_benign (0.08) | -6.37 | chr4-120060123-C-T |
| 174 | D→N | missense_variant | ClinVar | Uncertain significance | — | — | likely_benign (0.08) | -6.37 | ClinVar:2539636 |
305 variants in the shared canonical core.
LoF = frameshift / stop-gain / splice-disrupting — inherently loss-of-function, flagged by consequence (AlphaMissense and ESM-C score only missense/substitutions, so they are blank here by design, not by absence of impact). AlphaMissense is computed in the canonical reading frame, so it scores the shared core but reads N/A across an isoform-unique extension — use ESM-C ΔLLR there.